Grey Street Capital »

Rxsight shares owned by Grey Street Capital

Quarter-by-quarter ownership of Rxsight (RXST) shares owned by Grey Street Capital from 13F filings

Historical chart of Grey Street Capital investment in Rxsight

Tip: Access up to 7 years of quarterly data

All positions including Rxsight held by Grey Street Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rxsight by Grey Street Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $978k 19k 51.58
2023-12-31 $765k 19k 40.32

More positions owned by Grey Street Capital

NVIDIA Corporation (NVDA)
Eli Lilly & Co. (LLY)
Accenture Plc Ireland Shs Class A (ACN)
Microsoft Corporation (MSFT)
Apple (AAPL)
Vertex Pharmaceuticals Incorporated (VRTX)
Meta Platforms Cl A (META)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Crowdstrike Hldgs Cl A (CRWD)
Adobe Systems Incorporated (ADBE)
Goldman Sachs (GS)
Agnico (AEM)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Grey Street Capital

Top funds holding Rxsight

BlackRock
Millennium Management
Vanguard Group
D. E. Shaw & Co
Artisan Partners Limited Partnership
No Street GP
Citadel Advisors
Morgan Stanley
Deutsche Bank Aktiengesellschaft
Bnp Paribas Arbitrage, Snc
State Street Corporation
Brown Capital Management
Geode Capital Management
UBS Group
Two Sigma Advisers

View all funds holding Rxsight